GTG's objectives are being realised.
Check out the chairmans addresses. Check out the progress. No false promises!!!! The first license was originally hoped for by mid last year. That time frame was obviously far too optimistic, but at least it is now happening.
NAS listing.
GTG is pursuing a responsible blend of commercial activities with R&D, nothing to suggest otherwise.
Plenty of blue sky for the medium to long term holders.
Check out Dr Jacobson.
The market likes GTG (the market has punished other BioTechs).
Thoughts, page-3
Add GTG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.010(8.33%) |
Mkt cap ! $14.54M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.0¢ | $3.139K | 26.86K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 46 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 33251 | 1 |
View Market Depth
| Last trade - 15.10pm 24/05/2024 (20 minute delay) ? |
| GTG (ASX) Chart |